SMTL ID : 8p0m.1

Crystal structure of TEAD3 in complex with IAG933

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 1.96 Å
Oligo State
hetero-2-2-mer
Ligands
3 x 1PG: 2-(2-{2-[2-(2-METHOXY-ETHOXY)-ETHOXY]-ETHOXY}-ETHOXY)-ETHANOL(Non-covalent)
2 x MYR: MYRISTIC ACID(Covalent)
4 x WCF: 4-[(2~{S})-5-chloranyl-6-fluoranyl-2-phenyl-2-[(2~{S})-pyrrolidin-2-yl]-3~{H}-1-benzofuran-4-yl]-5-fluoranyl-6-(2-hydroxyethyloxy)-~{N}-methyl-pyridine-3-carboxamide(Non-covalent)
2 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Chapeau, E.A. et al., Direct and selective pharmacological disruption of the YAP-TEAD interface by IAG933 inhibits Hippo-dependent and RAS-MAPK-altered cancers. Nat Cancer (2024)
Release Date
2024-04-10
Peptides
Transcriptional enhancer factor TEF-5: AB
Transcriptional enhancer factor TEF-5: CD
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A
B
B
C
C
D
D

Transcriptional enhancer factor TEF-5

Transcriptional enhancer factor TEF-5

Related Entries With Identical Sequence

8a0u.1 | 8a0u.2 | 8a0u.3 | 8a0u.4 | 8a0v.1 | 8a0v.2 | 8a0v.3 | 8a0v.4